Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina L Haass-Koffler

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Addiction (Abingdon, England)|February 20, 2026
Glucagon-like peptide-1 receptor agonists in alcohol use disorder: Multi-system effects, early clinical promise and uncertain long-term useCarolina L Haass-Koffler
Alcoholism, Clinical and Experimental Research|April 29, 2020
Protein Tyrosine Phosphatase β/ζ and Alcohol Use Disorder: A CommentaryCarolina L Haass-Koffler
Alcohol (Fayetteville, N.Y.)|March 8, 2018
The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?Carolina L Haass-Koffler
Alcohol, Clinical & Experimental Research|February 28, 2023
Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonistCarolina L Haass-Koffler
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 18, 2020
Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use DisorderCarolina L Haass-Koffler, Roberta Perciballi
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 26, 2019
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and LimitationsKimberly Goodyear, Carolina L Haass-Koffler
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use DisordersCarolina L Haass-Koffler, Jesse R Schank
Frontiers in Molecular Neuroscience|September 14, 2012
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticityCarolina L Haass-Koffler, Selena E Bartlett
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 2023
Neuroscience targets and human studies: future translational efforts in the stress systemCarolina L Haass-Koffler, Douglas J Sheffler
European Journal of Internal Medicine|May 15, 2026
Alcohol use: less is better. Shifting the clinical paradigm from 'safe thresholds' to risk reductionCarolina L Haass-Koffler, Stephanie L Foster
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Addiction (Abingdon, England)|February 20, 2026
Glucagon-like peptide-1 receptor agonists in alcohol use disorder: Multi-system effects, early clinical promise and uncertain long-term useCarolina L Haass-Koffler
Alcoholism, Clinical and Experimental Research|April 29, 2020
Protein Tyrosine Phosphatase β/ζ and Alcohol Use Disorder: A CommentaryCarolina L Haass-Koffler
Alcohol (Fayetteville, N.Y.)|March 8, 2018
The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?Carolina L Haass-Koffler
Alcohol, Clinical & Experimental Research|February 28, 2023
Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonistCarolina L Haass-Koffler
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 18, 2020
Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use DisorderCarolina L Haass-Koffler, Roberta Perciballi
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 26, 2019
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and LimitationsKimberly Goodyear, Carolina L Haass-Koffler
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 23, 2020
Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use DisordersCarolina L Haass-Koffler, Jesse R Schank
Frontiers in Molecular Neuroscience|September 14, 2012
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticityCarolina L Haass-Koffler, Selena E Bartlett
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 2023
Neuroscience targets and human studies: future translational efforts in the stress systemCarolina L Haass-Koffler, Douglas J Sheffler
European Journal of Internal Medicine|May 15, 2026
Alcohol use: less is better. Shifting the clinical paradigm from 'safe thresholds' to risk reductionCarolina L Haass-Koffler, Stephanie L Foster
Pageof 7